Skip to main content
. 2021 Oct 25;59(5):292–301. doi: 10.5114/reum.2021.110318

Table II.

Comparison of the immunosenescence markers between healthy controls and systemic lupus erythematosus patients

Variable Healthy controls (n = 53) SLE patients (n = 53) p-value
CD4+CD57+ [%] 1.0 (0.4–1.4) 1.2 (0.6–2.8) 0.108
CD4+KLRG1+ [%] 0.3 (0.1–0.5) 3.1 (1.3–5.5) 0.000*
CD8+CD57+ [%] 2.4 ±2.0 11.6 ±7.1 0.000*
CD8+KLRG1+ [%] 0.3 ±0.1 13.7 ±7.5 0.000*
IFN-γ levels [pg/ml] 6.2 (5.3–8.9) 193.1 (139.1–225.1) 0.000*

IFN-γ – interferon γ, KLRG1 – killer cell lectin like receptor G1

*

p < 0.05 considered significant.